Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Ruiz

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Neurosurgery Practice|February 17, 2025
Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain MetastasesMohammed Abdulhaleem, Hannah Johnston, Ralph D'Agostino, et al.
Cancer Letters|February 15, 2022
NEDD4 degrades TUSC2 to promote glioblastoma progressionTadas K Rimkus, Austin B Arrigo, Dongqin Zhu, et al.
Cancer Medicine|April 13, 2017
The Effects of smoking status and smoking history on patients with brain metastases from lung cancerRachel F Shenker, Emory R McTyre, Jimmy Ruiz, et al.
Practical Radiation Oncology|July 5, 2019
Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary?Michael K Farris, William H Wheless, Ryan T Hughes, et al.
Neuro-Oncology Practice|September 27, 2019
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primariesClaire M Lanier, Ryan Hughes, Tamjeed Ahmed, et al.
Oncotarget|December 20, 2017
Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgeryNatalie Alphonse-Sullivan, Glen B Taksler, Thomas Lycan, et al.
Clinical Lung Cancer|August 2, 2024
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving ImmunotherapiesMargaret R Smith, Yuezhu Wang, Caroline B Dixon, et al.
The International Journal of Biological Markers|March 12, 2019
Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trialAmmoren Dohm, Jing Su, Emory R McTyre, et al.
Scientific Reports|October 9, 2019
CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgeryMichael H Soike, Jennifer Logue, Shadi Qasem, et al.
Journal of Neuro-Oncology|February 15, 2022
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastasesMohammed Abdulhaleem, Hannah Johnston, Ralph D'Agostino, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Neurosurgery Practice|February 17, 2025
Patterns of Failure Outcomes for Combination of Stereotactic Radiosurgery and Immunotherapy for Melanoma Brain MetastasesMohammed Abdulhaleem, Hannah Johnston, Ralph D'Agostino, et al.
Cancer Letters|February 15, 2022
NEDD4 degrades TUSC2 to promote glioblastoma progressionTadas K Rimkus, Austin B Arrigo, Dongqin Zhu, et al.
Cancer Medicine|April 13, 2017
The Effects of smoking status and smoking history on patients with brain metastases from lung cancerRachel F Shenker, Emory R McTyre, Jimmy Ruiz, et al.
Practical Radiation Oncology|July 5, 2019
Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary?Michael K Farris, William H Wheless, Ryan T Hughes, et al.
Neuro-Oncology Practice|September 27, 2019
Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primariesClaire M Lanier, Ryan Hughes, Tamjeed Ahmed, et al.
Oncotarget|December 20, 2017
Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgeryNatalie Alphonse-Sullivan, Glen B Taksler, Thomas Lycan, et al.
Clinical Lung Cancer|August 2, 2024
Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving ImmunotherapiesMargaret R Smith, Yuezhu Wang, Caroline B Dixon, et al.
The International Journal of Biological Markers|March 12, 2019
Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trialAmmoren Dohm, Jing Su, Emory R McTyre, et al.
Scientific Reports|October 9, 2019
CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgeryMichael H Soike, Jennifer Logue, Shadi Qasem, et al.
Journal of Neuro-Oncology|February 15, 2022
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastasesMohammed Abdulhaleem, Hannah Johnston, Ralph D'Agostino, et al.
Pageof 10